Steven Rowe, MD, MSPH, With an Update on the Cystic Fibrosis Lung

In this podcast, Steven Rowe, MD, MSPH, talks about the recent advancements in the distribution of cells in human tissues that primarily mediate the abnormalities in cystic fibrosis, how these advancements have influenced treatment options for cystic fibrosis, and more.

Steven Rowe, MD, MSPH, is professor and director of the Cystic Fibrosis Research Center at the University of Alabama at Birmingham in Birmingham, Alabama. He is also an associate professor, director of the Center for CFTR Detection Core at Children's and UAB, and director of the Cystic Fibrosis Transition Program.

Additional Resources:

• Rowe S. A revised landscape of the cystic fibrosis lung. Talk presented at: IDWeek 2019; October 2-6, 2019; Washington, DC. https://cdmcd.co/n6EJ5.
• Harris JK, Wagner BD, Zemanick ET, et al; GOAL Investigators of the Cystic Fibrosis Foundation Therapeutics Development Network. Changes in airway microbiome and inflammation with ivacaftor treatment in patients with cystic fibrosis and the G551D mutation [published online October 11, 2019]. Ann Am Thorac Soc. https://doi.org/10.1513/AnnalsATS.201907-493OC. 
• Bell SC, Mall MA, Gutierrez H, et al. The future of cystic fibrosis care: a global perspective [published online September 27, 2019]. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(19)30337-6.

Disclosures:
Astra Zeneca: Grant/Research Support
Bayer: Grant/Research Support
Celtaxsys: Consultant, Grant/Research Support
Ionic: Grant/Research Support
ProQR: Consultant, Grant/Research Support
Synedgen: Grant/Research Support
Translate Bio: Grant/Research Support
Vertex: Consultant, Grant/Research Support